FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $79.8 million versus the consensus estimate of $76.2 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
... More
